Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 90 member A28, pseudogene (FAM90A28P), is classified as a pseudogene within the FAM90A family[1][2]. Pseudogenes are genomic DNA sequences resembling known genes but often contain mutations (e.g., frameshifts or premature stop codons) that prevent them from being translated into functional proteins[3][4]. While historically labeled as “junk DNA,” recent research shows that some pseudogenes can be transcriptionally active and may play regulatory roles in processes such as RNA interference, microRNA decoy, and gene expression modulation[3][4]. However, for FAM90A28P specifically, there is currently no direct evidence of such a role, and it is not characterized as a therapeutic target[1][2]. There are no known associated drugs, clinical biomarkers, or direct disease links.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 90 member A28, pseudogene (FAM90A28P).